Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,800
Closed -$40K 5675
2021
Q2
$40K Buy
+2,800
New +$140K ﹤0.01% 2681
2021
Q1
Sell
-10,000
Closed -$42K 5592
2020
Q4
$42K Sell
10,000
-40,600
-80% -$1.34M ﹤0.01% 2117
2020
Q3
$2K Buy
50,600
+45,300
+855% +$1.92M ﹤0.01% 3985
2020
Q2
$18K Buy
5,300
+3,200
+152% +$164K ﹤0.01% 2457
2020
Q1
$4K Buy
+2,100
New +$95K ﹤0.01% 3151

Other funds holding ATEX

Cutler Group's ATEX Position: Q4 2021 in Review

Cutler Group sold out of Anterix (ATEX) in Q4 2021, closing a stake of 1,200 shares — an estimated $72K sold.

Cutler Group first reported a position in ATEX in Q4 2019 and held it in 7 quarters. The position peaked at $470K in Q3 2020. 108 funds tracked by Wall St. Rank hold ATEX as of Q4 2021.

  • Cutler Group reported no remaining Anterix position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 1,200 Anterix shares in Q4 2021, an estimated $72K.
  • Cutler Group first reported a position in Anterix in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Anterix position peaked at $470K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Anterix as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.